SureClinical Supports Accelagen COVID-19 Phase 2 Trial
Seeking the Fastest Path to a COVID-19 Vaccine SureClinical, the premier provider of FDA and EU compliance validated eClinical cloud applications today announced its complimentary support for Accelagen Pty Ltd Phase 1/2 COVID-19 trial on the SureClinical Platform. Accelagen is an Australian-based full service clinical research and regulatory affairs CRO supporting the development of new …
SureClinical Supports Accelagen COVID-19 Phase 2 Trial Read More »